Schned AR - Search Results

1

Microsatellite instability at tetranucleotide repeats in skin and bladder cancer.

Danaee H, Nelson HH, Karagas MR, Schned AR, Ashok TD, Hirao T, Perry AE, Kelsey KT. Danaee H, et al. Among authors: schned ar. Oncogene. 2002 Jul 25;21(32):4894-9. doi: 10.1038/sj.onc.1205619. Oncogene. 2002. PMID: 12118368

2

Bladder cancer risk and personal hair dye use.

Andrew AS, Schned AR, Heaney JA, Karagas MR. Andrew AS, et al. Among authors: schned ar. Int J Cancer. 2004 Apr 20;109(4):581-6. doi: 10.1002/ijc.11729. Int J Cancer. 2004. PMID: 14991581

3

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer.

Kelsey KT, Hirao T, Schned A, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR. Kelsey KT, et al. Br J Cancer. 2004 Apr 19;90(8):1572-6. doi: 10.1038/sj.bjc.6601748. Br J Cancer. 2004. PMID: 15083187 Free PMC article.

4

Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.

Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A. Karagas MR, et al. Cancer Causes Control. 2004 Jun;15(5):465-72. doi: 10.1023/B:CACO.0000036452.55199.a3. Cancer Causes Control. 2004. PMID: 15286466

5

Occupation and bladder cancer risk in a population-based case-control study in New Hampshire.

Colt JS, Baris D, Stewart P, Schned AR, Heaney JA, Mott LA, Silverman D, Karagas M. Colt JS, et al. Among authors: schned ar. Cancer Causes Control. 2004 Oct;15(8):759-69. doi: 10.1023/B:CACO.0000043426.28741.a2. Cancer Causes Control. 2004. PMID: 15456989

6

TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer.

Kelsey KT, Hirao T, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Colt J, Baris D, Morris JS, Schned A, Karagas M. Kelsey KT, et al. Int J Cancer. 2005 Nov 10;117(3):370-5. doi: 10.1002/ijc.21195. Int J Cancer. 2005. PMID: 15906354

7

Carcinogen exposure and gene promoter hypermethylation in bladder cancer.

Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Marsit CJ, et al. Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987713

8

Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.

Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT. Marsit CJ, et al. Among authors: schned ar. Cancer Res. 2005 Aug 15;65(16):7081-5. doi: 10.1158/0008-5472.CAN-05-0267. Cancer Res. 2005. PMID: 16103055

9

Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.

Hirao S, Hirao T, Marsit CJ, Hirao Y, Schned A, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR, Kelsey KT. Hirao S, et al. Cancer. 2005 Nov 1;104(9):1918-23. doi: 10.1002/cncr.21423. Cancer. 2005. PMID: 16149093 Free article.

10

Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study.

Karagas MR, Park S, Nelson HH, Andrew AS, Mott L, Schned A, Kelsey KT. Karagas MR, et al. Int J Hyg Environ Health. 2005;208(5):321-7. doi: 10.1016/j.ijheh.2005.04.005. Int J Hyg Environ Health. 2005. PMID: 16217917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters